2000
|  |
|
|
| Sino Biopharmaceutical Ltd successfully listed on the Growth Enterprise Market (GEM) of The Stock Exchange of Hong Kong Limited (Stock Code: 0827) |
|
|
|
2003
| 
|
|
|
| Sino Biopharmaceutical Ltd successfully listed on the Main Board of The Stock Exchange of Hong Kong Limited (Stock Code: 1177) |
|
|
|
2005
| 
|
|  |
| U.S. eye health giant Bausch & Lomb acquired a controlling stake in Shandong Chia Tai Freda Pharmaceutical Group from Sino Biopharmaceutical Ltd. for US$200 million |
| Sino Biopharmaceutical Ltd. was awarded “200 Best Companies under $1 Billion in Asia Pacific” by Forbes |
|
2006
|  |
|
|
| The Company was awarded “Chinese Outstanding Enterprise Achievement Prize” by the Capital Magazine in May, 2006 |
|
|
|
2015
|  |
|
|
| Sino Biopharmaceutical Limited debut in “China's Top 500 Companies” by Fortune China ranking 447 |
|
|
|
2016
|  |
| 
|
| Sino Biopharmaceutical Limited was ranked #410, up 37 spots from the year before in “China's Top 500 Companies” by Fortune China |
| Sino Biopharmaceutical Limited became one of three public companies to make it on Forbes Asia Fabulous 50 (Fab 50) |
|